Reuters logo
BRIEF-Edwards enters into agreement to acquire Valtech Cardio
November 28, 2016 / 11:22 AM / a year ago

BRIEF-Edwards enters into agreement to acquire Valtech Cardio

Nov 28 (Reuters) - Edwards Lifesciences Corp

* Edwards enters into agreement to acquire Valtech Cardio

* Purchase price of Valtech is $340 million in stock and cash at closing,

* Prior to close of transaction, Valtech will spin off its early-stage transseptal mitral valve replacement technology program

* Edwards will retain an option to acquire that program and its associated intellectual property

* Valtech has initiated ce mark trial for tricuspid application of similar version of device, intended to reduce tricuspid regurgitation

* Edwards’ board authorized a new share repurchase program to acquire up to an additional $1 billion outstanding common shares

* Deal includes potential for up to $350 million of purchase price in additional milestone-driven payments over next 10 years Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below